Knight Therapeutics | GUD - Ebitda



Knight Therapeutics reported CAD16.72M in EBITDA for its fiscal quarter ending in September of 2024.


Ebitda Change Date
Acasti Pharma USD -4829000 133K Sep/2024
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Aurora Cannabis CAD -11427000 13.94M Jun/2025
Avita Medical AUD -9863000 3.95M Dec/2024
Canopy Growth CAD -21827000 13.2M Jun/2025
Cronos Group USD 1.69M 2.75M Jun/2025
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Moderna USD -760000000 164M Jun/2025
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Organon & Co USD 522M 114M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Tectonic Therapeutic USD -13483000 5.73M Dec/2024
Tilray USD -101000 2.32M Nov/2024
Viatris USD 1.08B 218.1M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025